Jackson Thornton Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,297
Closed -$237K 296
2025
Q4
$237K Buy
+1,297
New +$212K 0.02% 261

Other funds holding BIIB

Jackson Thornton Wealth Management's BIIB Position: Q1 2026 in Review

Jackson Thornton Wealth Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 1,297 shares — an estimated $237K sold.

Jackson Thornton Wealth Management first reported a position in BIIB in Q4 2025 and held it in 1 quarter. The position peaked at $237K in Q4 2025. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Jackson Thornton Wealth Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Jackson Thornton Wealth Management sold 1,297 Biogen shares in Q1 2026, an estimated $237K.
  • Jackson Thornton Wealth Management first reported a position in Biogen in Q4 2025 and held it in 1 quarter.
  • Jackson Thornton Wealth Management's Biogen position peaked at $237K in Q4 2025.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.